• Skip to Main Content
Viatris
Hamburger menu icon
Show Menu
Change Location
English (Canada)
  • English (Canada)
  • français (Canada)
Choose Your Location
X
Global Visit our Corporate site
  • Australia
    • Austria
      • Belgium
        • Dutch
        • French
      • Brazil
        • Bulgaria
          • Canada
            • English
            • French
          • China
            • Croatia
              • Czech Republic
                • Denmark
                  • Estonia
                    • Finland
                      • France
                        • GermanyGermany
                          • Greece
                            • Hong Kong
                              • Hungary
                                • India
                                  • Ireland
                                    • Italy
                                      • Japan
                                        • Korea
                                          • Latvia
                                            • Lithuania
                                              • Malaysia
                                                • Mexico
                                                  • Netherlands
                                                    • New Zealand
                                                      • Norway
                                                        • Philippines
                                                          • Poland
                                                            • Portugal
                                                              • Romania
                                                                • Russia
                                                                  • Saudi Arabia
                                                                    • Arabic
                                                                    • English
                                                                  • Serbia
                                                                    • Slovakia
                                                                      • Slovenia
                                                                        • South Africa
                                                                          • Spain
                                                                            • Sweden
                                                                              • Switzerland
                                                                                • German
                                                                                • French
                                                                              • Taiwan
                                                                                • Thailand
                                                                                  • Türkiye
                                                                                    • United Kingdom
                                                                                      • United States
                                                                                          • About Us
                                                                                            • Our Story
                                                                                            • Executive Leadership Team
                                                                                            • Our Culture
                                                                                            • Global Sustainability
                                                                                            • Global Healthcare Gateway
                                                                                            • Public Policy
                                                                                            • Contact us
                                                                                          • Products
                                                                                            • Branded Specialty
                                                                                            • Product Catalogue
                                                                                          • Newsroom
                                                                                            • Featured Stories
                                                                                          • Careers
                                                                                            • Career FAQ
                                                                                            • Diversity and Inclusion
                                                                                            • Search Careers
                                                                                          • Investors
                                                                                            • Events and Presentations
                                                                                            • Financials and Filings
                                                                                            • Stock Information
                                                                                            • Shareholder Toolkit
                                                                                            • Frequently Asked Questions

                                                                                          Leaving the Viatris site

                                                                                          You are now leaving the Viatris Canada page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

                                                                                          Continue
                                                                                          Cancel

                                                                                          Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada

                                                                                          New generic Multiple Sclerosis treatment option, PrGlatiramer Acetate Injection 20 mg/mL for once-daily injection, available for one of the largest MS populations in the world

                                                                                          ETOBICOKE, ON April 15, 2024 /CNW/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the launch in Canada of PrGlatiramer Acetate Injection 20 mg/mL for once-daily injection, the first generic bioequivalent version of Teva's Copaxone® 20 mg/mL, indicated for the treatment of patients with Relapsing-Remitting Multiple Sclerosis (RMMS), a chronic inflammatory disease of the central nervous system.

                                                                                          Viatris Canada's Country Manager Jeffrey Long commented, "The launch of Glatiramer Acetate Injection 20 mg/mL, the first bioequivalent generic for Copaxone® 20 mg/mL, marks another significant milestone for Viatris Canada, reinforcing our proven capabilities in bringing complex and difficult-to-manufacture products to market, and furthering our commitment to providing access to high quality medicines. MS Canada estimates 90,000 Canadians are living with Multiple Sclerosis—one of the highest rates of MS in the world.i Because of this high prevalence, and because MS affects each person differently, there is a need for a range of medicines to help manage the symptoms of the disease and other medical conditions that are commonly associated with MS."

                                                                                          Glatiramer Acetate Injection 20 mg/mL for once daily injection was approved as a therapeutic equivalent to Copaxone® 20 mg/mL. Viatris generated bioequivalency and characterization data on this product, formulated to have the same dosage form, route of administration and strength as the branded counterpart. Glatiramer Acetate Injection 20 mg/mL is available by prescription only.ii

                                                                                          A comprehensive patient support program, VIATRIS ADVOCATE™, offers services for patients including reimbursement navigation, financial assistance for eligible patients, injection training and on-going support from MS-experienced nurses.

                                                                                          For more information, please consult the Glatiramer Acetate Product Monograph at: https://pdf.hres.ca/dpd_pm/00072479.PDF

                                                                                          About Viatris
                                                                                          Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).

                                                                                          • Privacy Policy
                                                                                          • Cookie Notice
                                                                                          • Terms of Use
                                                                                          • California Supplemental Disclosure
                                                                                          • California Supply Chain Transparency, UK and Australia Modern Slavery Statement
                                                                                          • Privacy Policy
                                                                                          • Viatris Compliance Line
                                                                                          • Contact us
                                                                                          • Terms of Use
                                                                                          • Cookie Notice
                                                                                          • Products
                                                                                          • Investors
                                                                                          • Newsroom
                                                                                          • Careers
                                                                                          • About Us
                                                                                          • Sitemap
                                                                                          • Accessibility
                                                                                          • linkedin
                                                                                          • instagram
                                                                                          • twitter
                                                                                          • youtube

                                                                                          Visit our Corporate site

                                                                                          viatris.com

                                                                                          © 2025 Viatris Inc. All Rights Reserved. VIATRIS, the Viatris Logo, the Global Healthcare Gateway logo and PARTNER OF CHOICE are trademarks and GLOBAL HEALTHCARE GATEWAY is a registered trademark of Mylan Inc., a Viatris company.